1. A pilot screening of high-risk Gaucher disease children using dried blood spot methods in Shandong province of China.
- Author
-
Lei, Ke, Zhao, Yanxia, Sun, Lirong, Liang, Hui, Luo, Ronghua, Sun, Xiaojing, Tao, Yanling, Chen, Lijun, Zhang, Lingling, Li, Aimin, Li, Fu, and Ding, Hongfang
- Subjects
GAUCHER'S disease ,DRIED blood spot testing ,MONOCLONAL gammopathies ,DISEASE prevalence ,SYMPTOMS - Abstract
Background: The study aim was to verify the feasibility of a diagnostic algorithm with the evaluation of beta glucocerebrosidase (GBA) activity on dried blood spots (DBS) in screening high-risk Gaucher disease (GD) children in China, and to investigate the GD prevalence in this selected population.Methods: Children were recruited from 20 departments of pediatrics or children's hospitals in Shandong Province, China, due to splenomegaly and/or thrombocytopenia associated with one or more of the following creteria: anemia, history of bone pain, monoclonal gammopathy of unknown significance (MGUS), polyclonal gammopathy and splenectomy. GBA activity on DBS was tested, and patients with DBS GBA activity under 30 nmol/h.ml were recalled to assess enzyme assay with gold standard and molecular GBA gene analysis on leukocytes.Results: A total of 73 children (47 boys and 26 girls) were enrolled in this study. GBA activity DBS < 30 nmol/h.ml was found in 18 (23.7%) children among which four (three boys and one girl) were diagnosed as GD with a median age 1.5 years, and the prevalence in this pediatric population was 5.5% (1.5%~ 13.4%). Three new mutations of GBA found in the four GD patients, L264I, A100Cfs*7 and D399E, have not been reported before.Conclusions: With evaluation of GBA activity on DBS as a preliminary screening method, the diagnostic algorithm used in this study is appropriate to make early diagnosis for GD patients with mild symptoms or atypical symptoms and avoid diagnosis delay.Trial Registration: Not applicable. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF